Anupam Rasayan India Limited has reported strong financial performance for the quarter ended June 30, 2026, marking a positive start to FY27. The company, one of India’s leading custom synthesis and specialty chemical players, reported significant year-on-year growth in revenue and EBITDA. Anupam Rasayan’s consolidated revenue reached Rs 6,675 million in Q1 FY27, compared with Rs 4,907 million in Q1 FY26, representing a 36% year-on-year increase. The company also recorded strong operating profitability during the quarter. EBITDA, including other income, increased 35% YoY to Rs 1,749 million, compared with Rs 1,292 million in the corresponding quarter last year. This translated into an EBITDA margin of 26.2% in Q1 FY27. Meanwhile, Profit After Tax (PAT) stood at Rs 512 million, compared with Rs 485 million in Q1 FY26.

Flow Chemistry Milestone Strengthens Fluorination Capabilities

Anand Desai, Managing Director, Anupam Rasayan India Limited, said the company began FY27 on a strong footing, with consolidated revenue growing 36% year-on-year. He highlighted the company’s continued progress towards building a globally integrated specialty chemicals and CDMO platform. During the quarter, Anupam Rasayan achieved a significant technological milestone by becoming the first company globally to commercialize Ethyl Trifluoroacetate (ETFA) using flow chemistry. The development strengthens the company’s capabilities in complex fluorination chemistry and demonstrates its focus on advanced manufacturing technologies.

BASQUEVOLT Deal Opens US$300 Million Opportunity

Further strengthening its growth pipeline, Anupam Rasayan signed a Letter of Intent (LoI) with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product. The agreement represents a potential revenue opportunity of approximately US$300 million over ten years. Consequently, the proposed partnership could provide a significant long-term growth opportunity for the company while expanding its presence in advanced specialty chemicals.

Bliss GVS Pharma Acquisition Progresses

Meanwhile, Anupam Rasayan’s proposed acquisition of Bliss GVS Pharma is progressing as planned following the signing of a definitive agreement. The company expects the acquisition to strengthen its pharmaceutical platform by creating synergies across CDMO capabilities, product development, customer relationships and access to regulated markets.

Strong Pipeline Supports FY27 Growth Outlook

Looking ahead, Anupam Rasayan remains confident about its growth prospects. The company expects its strong product pipeline, expanding opportunities in Performance Materials and Pharmaceuticals, deeper customer engagement, and continued investments in technology and innovation to support future growth. As per the press release, these initiatives are expected to strengthen Anupam Rasayan’s specialty chemicals and pharmaceutical businesses while supporting sustainable growth and long-term value creation.

The government has received 20 bids from domestic and international companies to establish integrated manufacturing facilities for sintered neodymium-iron-boron (NdFeB) rare earth permanent magnets (REPMs). The response marks a significant step towards reducing India’s dependence on imported rare earth magnets, which are critical for industries such as electric mobility, renewable energy, electronics and advanced manufacturing.

Major Companies Join the Bidding

The Ministry of Heavy Industries (MHI) opened the technical bids after receiving applications through the government’s e-procurement portal. The bidders include Larsen & Toubro, Coal India, 20 Microns, Attero Recycling, Lohum Magnets & Energy Solutions, Prozeal Green Energy, Singapore-based NEO Performance Materials, Proterial (India), PrNd Metal and Magnets, and the Midwest Energy–Midwest Advanced Materials joint venture, among others. The participation of both established industrial companies and specialised materials firms highlights growing interest in developing India’s domestic rare earth magnet manufacturing capabilities.

₹7,280 Crore Scheme Targets 6,000 MTPA Capacity

The Union Cabinet approved the rare earth permanent magnet manufacturing scheme in November 2025 with a total financial outlay of ₹7,280 crore. The programme aims to establish 6,000 metric tons per annum (MTPA) of integrated REPM manufacturing capacity in India. Under the scheme, the government will select five beneficiaries through global competitive bidding, with each beneficiary eligible to establish up to 1,200 MTPA of capacity.

Building an Integrated Rare Earth Value Chain

The scheme will run for seven years, comprising a two-year gestation period for establishing manufacturing facilities followed by five years of incentives linked to REPM sales. Importantly, the programme aims to develop an integrated domestic value chain covering the conversion of neodymium-praseodymium (NdPr) oxide into finished rare earth magnets. By developing capabilities across the value chain, India aims to improve supply security and reduce exposure to global disruptions in critical mineral and magnet markets.

Supporting India’s Clean Energy and Manufacturing Goals

The government expects the initiative to strengthen domestic supply chains for critical industries while improving India’s competitiveness in the global rare earth permanent magnet market. Increased domestic REPM production could support strategic sectors including electric vehicles, wind energy, electronics and advanced industrial technologies. As reported by msn.com, the programme aligns with India’s broader clean-energy objectives and is expected to contribute to the country’s target of achieving net-zero emissions by 2070.

The government is accelerating plans to establish four dedicated critical mineral processing parks across the country as it seeks to strengthen domestic mineral processing and build secure supply chains for strategic materials. Mines Secretary Keshav Chandra said the government will soon introduce measures for lithium and nickel while identifying suitable locations for the proposed parks. Gujarat and Maharashtra are among the states being considered.

Focus on Lithium and Nickel Processing

The government’s initial focus on lithium and nickel reflects their growing importance in the battery manufacturing and clean-energy sectors. Both minerals are expected to play an increasingly important role in India’s energy transition and future industrial growth. Each proposed park will be designed to support the complete value chain of a designated critical mineral. This will include mineral processing as well as downstream industries within an integrated industrial location.

States to Lead Park Development

State governments will lead the planning and implementation of the critical mineral parks, while the Centre will provide technical support. By bringing processing and downstream manufacturing together, the initiative aims to improve efficiency, encourage investment and strengthen India’s domestic capabilities across the critical mineral value chain.

₹34,300 Crore National Critical Mineral Mission

The initiative forms part of the National Critical Mineral Mission, which carries a total outlay of ₹34,300 crore over seven years. The mission aims to accelerate domestic and overseas mineral exploration, develop processing capabilities and strengthen India’s access to critical raw materials. As reported by projectstoday.ai, the proposed processing parks could support India’s broader green-energy transition, while reducing vulnerabilities in the supply of minerals required for batteries, clean technologies and advanced industrial applications.

Larsen & Toubro’s AI infrastructure company, Vyoma.AI, through its subsidiary LTN Compute, has secured a major order to develop India’s largest single-cluster AI infrastructure facility, featuring an NVIDIA B300 AI Factory, for a US-based AI cloud innovator. The AI Factory will support large-scale AI inference, fine-tuning and training workloads, strengthening India’s AI infrastructure ecosystem while enabling global AI innovation.

Chennai Campus to Host 10,000 NVIDIA GPUs

The AI Factory will be deployed at Vyoma.AI’s Chennai data centre campus, a gigawatt-scale AI infrastructure site designed to support future expansion. Phase 1 of the campus is designed for 250 MW, with power infrastructure readiness of 150 MVA. This capacity provides a scalable foundation for deploying and expanding advanced AI computing infrastructure. The integrated AI Factory will feature 10,000 NVIDIA B300 GPUs. It will combine hyperscale data centre infrastructure with accelerated computing, high-performance networking, ultra-low-latency interconnects and high-throughput parallel storage. Together, these capabilities will provide an integrated, end-to-end AI infrastructure stack, allowing customers to deploy and scale demanding AI workloads more efficiently.

L&T Strengthens India’s AI Infrastructure

The project forms part of L&T’s broader Gigawatt AI Infrastructure Mission and reflects the company’s strategy to build large-scale AI-ready infrastructure in India. S N Subrahmanyan, Chairman & Managing Director, Larsen & Toubro, said AI is becoming foundational across industries and that AI Factories will play a critical role in supporting this transformation. He added that the deployment reinforces L&T’s commitment to positioning India as a global hub for next-generation AI infrastructure.

Together AI Partnership Targets Global AI Demand

Vipul Ved Prakash, Co-founder & CEO of Together AI, said the company partnered with L&T to bring the scale, resilience and engineering capabilities required to expand global access to AI infrastructure. The collaboration will therefore combine L&T’s infrastructure capabilities with Together AI’s AI cloud platform to support rapidly growing demand for large-scale AI computing.

LTN Compute Expands AI Infrastructure Portfolio

LTN Compute is developing AI-ready digital infrastructure across India through hyperscale AI data centres, sovereign cloud platforms, AI Factory services, GPU-as-a-Service (GPUaaS) and managed AI platforms. These solutions are designed to support governments, enterprises, cloud providers and AI innovators as demand for high-performance computing and AI infrastructure continues to accelerate. As per the press release, the deployment of the NVIDIA B300 AI Factory marks a significant step in L&T’s expansion into large-scale AI infrastructure and strengthens Chennai’s role in India’s emerging AI data centre ecosystem.

DCW announced a strategic investment programme of approximately ₹250 crore, marking the first phase of its next growth cycle. The company will use the investment to expand its Synthetic Iron Oxide Pigment (SIOP) capacity, develop value-added pigment products and strengthen captive power infrastructure at its Sahupuram manufacturing complex. The programme reflects DCW’s continued shift towards higher-value chemical businesses while supporting its long-term growth strategy.

SIOP Capacity to Rise to 45,000 TPA

As part of the expansion, DCW plans to increase its SIOP production capacity by 50%, from approximately 30,000 tonnes per annum (TPA) to 45,000 TPA through a phased investment programme. The expansion follows record SIOP sales volumes in FY26, when the business operated effectively at full capacity. By adding capacity, DCW aims to meet growing demand in both domestic and international markets. The company expects the expansion to benefit from a sizeable global iron oxide pigments market and diversified demand across multiple end-use industries.

Global Iron Oxide Pigments Market Offers Growth Potential

Recent industry estimates value the global iron oxide pigments market at approximately US$2.5–2.7 billion in 2025. The market is projected to reach around US$3.9 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 4.6%. Meanwhile, Asia-Pacific remains the largest regional market, accounting for approximately 41.5% of global revenue in 2025. This market outlook provides a favourable backdrop for DCW’s planned SIOP capacity expansion.

Focus Shifts Towards Value-Added Chemicals

The investment programme builds on DCW’s multi-year transition towards higher-value specialty chemicals. Between FY21 and FY25, the company’s Specialty Chemicals segment recorded a 26% CAGR, while Specialty Chemicals EBITDA in FY25 reached 1.9 times FY21 levels. Over the past five years, Specialty Chemicals have also become a major contributor to DCW’s profitability. Consequently, the business has developed a more resilient earnings base and reduced its exposure to fluctuations in Basic Chemicals.

Pigment Grades to Expand Product Portfolio

In addition to increasing production capacity, DCW plans to introduce new value-added SIOP grades. These products will broaden the company’s portfolio and help it address higher-value applications and evolving customer requirements. The company had previously indicated that its SIOP product development strategy would increasingly focus on value-added grades alongside volume expansion.

Captive Power Investment to Improve Efficiency

DCW will also invest in captive power infrastructure at Sahupuram. The initiative aims to improve energy efficiency and strengthen the cost competitiveness of both its Basic Chemicals and Specialty Chemicals businesses. The company enters this investment cycle with a stronger balance sheet and is expected to become net cash positive by the end of FY27, before taking on additional leverage for the proposed capital expenditure. As reported by business-standard.com, the investment programme combines capacity expansion, product development and energy infrastructure improvements to strengthen DCW’s specialty chemicals platform and support its next phase of growth.

Lincoln Pharmaceuticals reported strong operational and financial performance for the quarter ended June 30, 2026. The company posted a consolidated net profit of ₹36.23 crore in Q1 FY27, up 30.90% from ₹27.68 crore in Q1 FY26. Total income increased 19.02% year-on-year to ₹201.55 crore, compared with ₹169.34 crore in the corresponding quarter last year. EBITDA also rose 32.29% to ₹51.70 crore, compared with ₹39.08 crore in Q1 FY26. The company reported an EPS of ₹18.09 per share.

Targeting ₹1,000 Crore Revenue

The company aims to achieve ₹1,000 crore in revenue over the next three years, supported by an annual growth target of 15–18%. Growth is expected across key therapeutic segments, including cardiac, diabetes, dermatology and ENT. At the same time, Lincoln Pharmaceuticals plans to expand its domestic and international presence by leveraging its manufacturing capabilities and product pipeline.

The company also remains focused on strengthening its presence across regulated and semi-regulated markets. It currently exports to more than 60 countries across East and West Africa, Central and North America, Latin America and Southeast Asia, and aims to expand its footprint to 90 countries within the next two to three years.

Expanding Global Market Presence

Lincoln Pharmaceuticals has recently entered the Canadian market and secured approvals from Australia’s TGA and EU-GMP, supporting its plans for further international expansion. CRISIL Ratings has also reaffirmed its ‘CRISIL A/Stable/CRISIL A1’ ratings on the company’s bank facilities. The ratings reflect its experienced promoters, established market position and healthy financial profile, although the company continues to face working-capital, regulatory and competitive challenges.

Manufacturing and Product Portfolio

Lincoln Pharmaceuticals operates a state-of-the-art manufacturing facility at Khatraj, Ahmedabad, Gujarat, which complies with international quality and regulatory standards. The facility holds certifications including EU-GMP, TGA, WHO-GMP, ISO 9001:2015, ISO 14001:2015 and ISO 45001:2018. The company has developed more than 600 formulations across 15 therapeutic areas, with a portfolio spanning anti-infectives, respiratory care, gynaecology, cardiovascular and CNS therapies, antibacterial and antidiabetic medicines, and antimalarial products. In addition, Lincoln Pharmaceuticals has filed more than 25 patent applications and secured seven patents. Its broader portfolio includes more than 1,700 registered products, with another 700 products currently under development.

Focus on Sustainable Growth

Munjal Patel, Director, Lincoln Pharmaceuticals, said the company has started FY27 with a focus on sustaining its growth momentum while strengthening its core business areas. He highlighted the company’s plans to expand across domestic and international markets while improving operational efficiency, broadening its product portfolio and maintaining disciplined execution. As per the press release, with a focus on innovation, global expansion and financial discipline, Lincoln Pharmaceuticals aims to cross the ₹1,000 crore revenue milestone while maintaining a debt-free balance sheet and delivering sustainable growth.

The three-day India Bioenergy & Tech Expo (IBET) 2026 concluded with investment commitments and MoUs worth approximately ₹15,000 crore, based on initial estimates. The strong investment interest highlights the growing momentum in India’s bioenergy sector while strengthening Uttar Pradesh’s position as an emerging hub for green energy investments.

Organised by the Indian Federation of Green Energy (IFGE) in partnership with the Uttar Pradesh New and Renewable Energy Development Agency (UPNEDA), the expo brought together policymakers, investors, technology companies, entrepreneurs and industry experts. The event explored opportunities across key segments, including compressed biogas (CBG), ethanol, biomass, biodiesel, waste-to-energy, bio-mobility, biomaterials and sustainable aviation fuel (SAF).

Focus on Farmers and Rural Bioenergy

A key highlight of the final day was the special session, “Fuelling Green Energy and Income Opportunities for Farmers.” Policymakers, industry leaders, technology providers and other stakeholders discussed ways to convert agricultural residues into clean energy while creating additional income opportunities for farmers. The discussions also highlighted the need to strengthen feedstock supply chains, improve farmer-industry partnerships and develop viable rural business models around bioenergy.

Uttar Pradesh Strengthens Bioenergy Ambitions

During the first two days, participants discussed India’s bioenergy roadmap, Uttar Pradesh’s growing role as an investment destination and the potential of CBG to transform agricultural waste into economic value. A.K. Sharma, Minister for Energy & Additional Sources of Energy, Government of Uttar Pradesh; Surya Pratap Shahi, Minister for Agriculture, Government of Uttar Pradesh; and Kailash Singh Rajput, Minister of State for Energy and Additional Sources of Energy, Government of Uttar Pradesh, participated in the three-day event along with senior Central and State Government officials. Sharma highlighted the potential of CBG to increase farmers’ incomes, generate rural employment and convert agricultural waste into productive economic assets. The Uttar Pradesh government also reiterated its support for entrepreneurs investing in the state’s bioenergy sector. Shahi noted that approximately ₹3,500 crore has already been invested in Uttar Pradesh’s CBG sector, The state could see another 70–80 CBG facilities in the coming period.

Bioenergy Moves Towards Scalable Investment

Sanjay Ganjoo, Director General, IFGE, said India’s bioenergy opportunity is increasingly moving from policy ambition towards large-scale investment and enterprise development. He emphasised that the next phase will require stronger feedstock supply chains, greater farmer participation, scalable projects and bankable business models. With appropriate policy support, technology and industry participation, bioenergy can simultaneously strengthen energy security, reduce waste, create rural employment and increase farmers’ incomes.

IBET 2026 Signals Strong Industry Momentum

The conclusion of IBET 2026 marks an important milestone for India’s growing bioenergy ecosystem. In particular, the scale of investment commitments demonstrates rising confidence in bioenergy as a strategic component of India’s clean-energy transition. As per the press release, as Uttar Pradesh strengthens its bioenergy infrastructure and attracts new investments, the sector could play an increasingly important role in supporting rural economic development, waste management, energy security and India’s broader green-energy ambitions.

Evonik Industries is supporting the next phase of Neptune Energy’s Altmark Lithium Extraction (ALE) Project in northern Germany. Following successful preliminary tests, Evonik’s Liocel® adsorbent has been selected as the first material for evaluation at the direct lithium extraction (DLE) pilot plant developed by Fraunhofer IEG. The project aims to advance lithium recovery from geothermal brine and strengthen Europe’s supply of critical raw materials.

Altmark Holds Significant Lithium Resources

The Altmark region in Saxony-Anhalt contains a project-specific lithium resource estimated at 43 million tonnes of lithium carbonate equivalent (LCE). Neptune Energy plans to recover lithium from geothermal brine using DLE technology. By developing a domestic lithium supply, the company aims to contribute to a more resilient European critical raw materials supply chain.

Pilot Phase I Identified Adsorption Technology

During Pilot Phase I, Neptune Energy evaluated several commercially available DLE technologies under conditions specific to the Altmark resource. The assessment included both ion-exchange and adsorption-based processes. Following the evaluation, Neptune selected adsorption technology for further testing in Pilot Phase II. For the next phase, Evonik’s Liocel® adsorbent will be the first material evaluated, supported by its demonstrated stability and strong performance during preliminary testing. Evonik will also contribute application and process expertise directly at the pilot site.

Fraunhofer Pilot Plant Enables Lithium Extraction

Fraunhofer IEG developed the pilot plant to demonstrate oxygen-free lithium extraction from geothermal brine. The facility can process up to 1,000 litres of geothermal brine per day. During Pilot Phase II, Neptune Energy will evaluate multiple adsorbent materials over the coming months. The results will help identify the most suitable technology for potential future industrial-scale lithium extraction from the Altmark resource.

Supporting Europe’s Lithium Supply Chain

The collaboration between Neptune Energy, Evonik and Fraunhofer IEG represents another step towards developing direct lithium extraction from geothermal resources. Michael Frey, Vice President and Head of Process Catalysts & Adsorbents at Evonik, said the company is pleased to support the next phase of the project and contribute its technical expertise. As per the press release, by testing adsorption-based lithium extraction under the specific conditions of the Altmark resource, the partners aim to advance a potential domestic source of lithium while supporting Europe’s broader efforts to secure critical raw materials.

Dutch circular chemistry technology developer BioBTX is building the world’s first commercial-scale plant to convert mixed plastic waste into high-quality aromatic chemicals. The facility will use BioBTX’s proprietary ICCP (Integrated Catalytic Cracking Process) technology to produce valuable chemical building blocks from waste that would otherwise be incinerated or sent to landfill. Covestro has been a shareholder and strategic partner of Groningen-based BioBTX since 2024, with a mid-single-digit million-euro investment.

New Plant to Create 35 Jobs

The facility will be constructed at Chemical Park Delfzijl on the northern coast of the Netherlands and is expected to create around 35 new jobs. BioBTX’s ICCP technology uses catalytic pyrolysis to process mixed plastic waste and convert it into aromatic oil containing benzene, toluene and xylenes (BTX). These chemicals serve as essential building blocks for a wide range of applications, including coatings, pharmaceuticals and performance materials. Furthermore, the resulting aromatics can be used to produce Covestro’s MDI and TDI isocyanates. These materials are used in polyurethane applications such as flexible foam for mattresses and rigid foam for refrigerator insulation.

Recycling 20,000 Tons of Waste Annually

Once operational, the plant is expected to recycle approximately 20,000 tonnes of plastic waste each year. At the same time, it is projected to produce around 10,000 tons of renewable aromatic oil and 8,000 tons of sustainable by-products annually. Importantly, the process could significantly reduce the environmental impact of aromatic chemical production. Compared with conventional fossil-based BTX production, BioBTX expects its technology to reduce greenhouse gas emissions from the resulting chemical building blocks by 70–80%.

Advancing Circular Chemical Production

According to Dr. Thorsten Dreier, Chief Technology Officer at Covestro, the project represents an important step in demonstrating the technology at industrial scale. He also highlighted the importance of processing mixed plastic waste rather than relying solely on highly sorted waste streams. This approach could help expand chemical recycling and support the transition towards a more circular plastics and chemicals industry.

From Laboratory Development to Commercial Scale

For BioBTX, the project represents the culmination of a 14-year development journey that began with an idea in 2012 and progressed through laboratory and pilot-scale development to commercial execution. Ton Vries, Co-founder and CEO of BioBTX, said the milestone represents a major step towards the company’s goal of enabling circular chemistry and developing a fully sustainable aromatic plant. As per the press release, while the first commercial facility will focus on mixed plastic waste, the company’s ICCP technology is feedstock-flexible. Consequently, BioBTX could potentially apply the technology to other feedstocks in the future, including biomass. The project therefore marks a significant step towards producing aromatic chemicals from alternative feedstocks while reducing dependence on conventional fossil-based raw materials.

A delegation led by the Managing Director of Adani Ports and Special Economic Zone, met Andhra Pradesh Chief Minister in Amaravati to discuss the proposed ₹16,000-crore titanium plant in Srikakulam district. The project is part of the Adani Group’s broader plans to develop value-added products from beach sand minerals and strengthen domestic mineral processing capabilities.

Project to Focus on Beach Sand Minerals

During the meeting, the Adani Group delegation briefed the Chief Minister on the potential of beach sand mining, mineral processing, industrial applications and market opportunities. The proposed project could process ilmenite, a titanium-bearing mineral found in beach sand, into higher-value products such as titanium slag, titanium dioxide and titanium sponge. These materials have applications across several industries, including paints, plastics and polymers, creating opportunities to build a broader domestic titanium value chain.

Adani Group Presents Visakhapatnam Development Plans

In addition to the titanium project, the group presented a Master Plan for a proposed data centre and IT park in Visakhapatnam. The plans also include the development of skill-development facilities, which could support workforce development alongside the group’s proposed industrial investments in the state.

Andhra Pradesh Pushes Integrated Mineral Value Chain

The Chief Minister called for an integrated value chain that prioritises domestic mineral processing and value addition. Such an approach could help maximise economic benefits from the state’s mineral resources, create higher-value industrial products and reduce India’s dependence on imports of critical minerals and processed materials. As reported by projectstoday.ai, the proposed titanium project could therefore strengthen Andhra Pradesh’s position in advanced mineral processing and downstream titanium manufacturing, while supporting the state’s broader industrial development goals.